Krane Funds Advisors LLC Pfizer Inc Transaction History

Krane Funds Advisors LLC

$2.34 Billion
Q1 2024

A detailed history of Krane Funds Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Krane Funds Advisors LLC holds 21,831 shares of PFE stock, worth $612,359. This represents 0.03% of its overall portfolio holdings.

Number of Shares

21,831

Previous 20,241 7.86%

Holding current value

$612,359

Previous $582,000 3.95%

% of portfolio

0.03%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$25.89 - $29.73 $41,165 - $47,270	1,590 Added 7.86%	21,831 $605,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $30,389 - $39,472	1,163 Added 6.1%	20,241 $582,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $69,378 - $81,096	2,162 Added 12.78%	19,078 $633,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $22,358 - $25,868	619 Added 3.8%	16,916 $620,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $61,645 - $80,253	1,565 Added 10.62%	16,297 $681,000

Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $615,061 - $802,894	14,732 New	14,732 $755,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $127,585 - $151,276	-2,742 Reduced 33.9%	5,347 $280,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $66,932 - $82,937	1,463 Added 22.08%	8,089 $419,000
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $100,531 - $149,021	-2,433 Reduced 26.86%	6,626 $391,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $355,565 - $456,754	9,059 New	9,059 $390,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $356,857 - $453,774	-10,662 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $338,518 - $397,159	10,662 New	10,662 $371,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.

Account

Krane Funds Advisors LLC Pfizer Inc Transaction History